Tofacitinib versus Methotrexate in Rheumatoid Arthritis

Eun Bong Lee, Roy Fleischmann, Stephen Hall, Bethanie Wilkinson, John D. Bradley, David Gruben, Tamas Koncz, Sriram Krishnaswami, Gene V. Wallenstein, Chuanbo Zang, Samuel H. Zwillich, Ronald F. van Vollenhoven
  • New England Journal of Medicine, June 2014, New England Journal of Medicine (NEJM/MMS)
  • DOI: 10.1056/nejmoa1310476

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Professor Antonio Fernandez-Nebro